Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2905-2026

Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECT Recall

Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECT Model/Catalog Number: NCOCO3010 Software Version: N/A Product Description: In situ polymerizing peripheral nerve repair device Component: No

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECT. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2905-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 15, 2026
FDA report date
Aug 12, 2026
Quantity in commerce
Not reported
Distribution
See key details
FDA cause
Incorrect or no expiration date

What is being recalled?

Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECT Model/Catalog Number: NCOCO3010 Software Version: N/A Product Description: In situ polymerizing peripheral nerve repair device Component: No

Affected model & UDI checker

Search the exact identifiers published for Z-2905-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
NCOCO3010Brand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECTCheck source noticeNot specified
Not specifiedBrand Name: COAPTIUM CONNECT Product Name: COAPTIUM CONNECTCheck source notice03760279380117
FDA code information

Lot Code: Model No NCOCO3010; UDI-DI 03760279380117; Lot Numbers 250700045, 251000040, 251000036, 251000037, 251000039, 251000035, and 251000064

View the original FDA recall notice

Why was this product recalled?

Currently labeled shelf life of 36 months is not substantiated by real-time data. Devices will be relabeled to reflect revised shelf life of 26 months. The use of a medical device beyond its validated shelf life may result in perioperative breakage of the device rendering device unusable; worst-case outcome would be revision surgery.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did TISSIUM SA take?

On June 25, 2026, the firm began notifying consignees via direct visit by medical representatives to deliver the Customer Recall Notification Letter in person. Representatives removed affected units from customer shelves, collected completed response forms, and provided conforming replacement product on the same day.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology